Prytime Medical Announces Appointment of Robert A. Cohen, M.D., to its Clinical Advisory Board
SAN ANTONIO, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Prytime Medical Devices Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products announced that board-certified obstetrician-gynecologist Robert A. Cohen, M.D., has joined the company's Clinical Advisory Board effective immediately.
- Dr. Cohen is the Medical Director of the Placenta Accreta Program at Medical City Dallas and is also a member of the AOA Honor Medical Society.
- He is invested in research and recently published a paper on improved placement location of REBOA catheter in pelvic hemorrhage.
- "Dr. Cohen joins the Prytime team as a highly recognized leader in the industry and brings first-hand clinical experience that transcends obstetrics," said David Spencer, Prytime Medical Devices, Inc.'s CEO.
- Dr. Cohen received his medical degree from Medical College of Wisconsin and completed residency at the University of Texas Southwestern Medical Center.